APA (7th ed.) Citation

S, D., S, M., K, A., X, R., P, A., GG, B., . . . HA, O. (2011). Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. Metabolic brain disease, 26(2), 123. https://doi.org/10.1007/s11011-011-9241-2

Chicago Style (17th ed.) Citation

S, Dziennis, et al. "Therapy with Recombinant T-cell Receptor Ligand Reduces Infarct Size and Infiltrating Inflammatory Cells in Brain After Middle Cerebral Artery Occlusion in Mice." Metabolic Brain Disease 26, no. 2 (2011): 123. https://doi.org/10.1007/s11011-011-9241-2.

MLA (9th ed.) Citation

S, Dziennis, et al. "Therapy with Recombinant T-cell Receptor Ligand Reduces Infarct Size and Infiltrating Inflammatory Cells in Brain After Middle Cerebral Artery Occlusion in Mice." Metabolic Brain Disease, vol. 26, no. 2, 2011, p. 123, https://doi.org/10.1007/s11011-011-9241-2.